TY - JOUR
T1 - Rethinking breast cancer follow-up based on individual risk and recurrence management
AU - De Rose, Fiorenza
AU - Meduri, Bruno
AU - De Santis, Maria Carmen
AU - Ferro, Antonella
AU - Marino, Lorenza
AU - Colciago, Riccardo Ray
AU - Gregucci, Fabiana
AU - Vanoni, Valentina
AU - Apolone, Giovanni
AU - Di Cosimo, Serena
AU - Delaloge, Suzette
AU - Cortes, Javier
AU - Curigliano, Giuseppe
N1 - Publisher Copyright:
© 2022
PY - 2022/9/1
Y1 - 2022/9/1
N2 - Current follow-up policies for early breast cancer aim to detect loco-regional recurrences and manage treatment-related adverse effects. Their “one size fits all” approach does not take into account differences in subtypes at initial diagnosis, individual prognosis and treatments received. They are derived from clinical trials conducted when early detection means - other than mammography - and treatment options were limited. Herein, we address the arguments for re-evaluating current breast cancer follow-up strategies starting from recent advances in breast cancer local and systemic treatments and discussing individual risk of recurrence prediction models, time-adapted imaging and biomarker assessment for disease diagnostic anticipation. This change in perspective would transform breast cancer follow-up into an integrated, multidisciplinary team medical practice. Hence we discuss the important role of patient-centered approaches, but also of general practitioners and other health professionals, in the final promotion of personalized surveillance programs and patient education.
AB - Current follow-up policies for early breast cancer aim to detect loco-regional recurrences and manage treatment-related adverse effects. Their “one size fits all” approach does not take into account differences in subtypes at initial diagnosis, individual prognosis and treatments received. They are derived from clinical trials conducted when early detection means - other than mammography - and treatment options were limited. Herein, we address the arguments for re-evaluating current breast cancer follow-up strategies starting from recent advances in breast cancer local and systemic treatments and discussing individual risk of recurrence prediction models, time-adapted imaging and biomarker assessment for disease diagnostic anticipation. This change in perspective would transform breast cancer follow-up into an integrated, multidisciplinary team medical practice. Hence we discuss the important role of patient-centered approaches, but also of general practitioners and other health professionals, in the final promotion of personalized surveillance programs and patient education.
KW - Breast cancer
KW - Follow-up
KW - Liquid biopsy
KW - Oligometastatic disease
KW - Personalized treatment
KW - Recurrence
UR - http://www.scopus.com/inward/record.url?scp=85135334786&partnerID=8YFLogxK
U2 - 10.1016/j.ctrv.2022.102434
DO - 10.1016/j.ctrv.2022.102434
M3 - Review article
C2 - 35933845
AN - SCOPUS:85135334786
SN - 0305-7372
VL - 109
JO - Cancer Treatment Reviews
JF - Cancer Treatment Reviews
M1 - 102434
ER -